In the first four projects of this Program Project Application, we have concentrated our efforts on studies of the normal bone resorption process and its regulation. In this project we will examine Paget's disease, a bone disorder in which osteoclast behavior is grossly distorted with greatly increased bone resorption followed by abundant new bone formation. The primary cellular abnormality occurs in osteoclasts. However, the mechanisms responsible for the abnormal bone remodeling the Paget's disease are unknown. We will use our recently developed human long term marrow cultures which form cells with osteoclast characteristics to investigate the pathobiology of Pagetic osteoclasts. Paget's disease offers a unique and ideal opportunity to study abnormal bone cells since the precursors for the abnormal cells, osteoclasts, can now be studied directly in long-term human marrow cultures. Therefore, we will determine: 1) the ultrastructure and light microscopic appearance of osteoclast-like cells from involved and uninvolved bone of patients with Paget's disease and contrast them to those from normals, 2) if viral inclusions are present in osteoclast-like cells using monoclonal antibodies and DNA probes for paramyxoviruses, 3) if conditioned media from long-term marrow cultures from patients with Paget's disease contain viral material and if coculture this conditioned media with marrow cells or osteoclasts results in transfer of the virus to these cells, 4) dose-response relationships for osteoclast-like cell formation with osteotropic hormones and inhibitors of osteoclast formation in cultures from Pagetic bone and uninvolved bone from the same patients and normal controls, and 5) if conditioned media from long-term marrow cultures of patients with Paget's disease contain factors which stimulate the growth, alkaline phosphatase activity and collagen production of osteoblasts from human bone biopsies as well as osteoblastic cell lines. In this manner we will for the first time critically examine the pathobiology of osteoclasts in Paget's disease.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Xu, S C; Harris, M A; Rubenstein, J L et al. (2001) Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2. DNA Cell Biol 20:359-65
Ji, X; Chen, D; Xu, C et al. (2000) Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab 18:132-9
Yoneda, T (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-5
Nishimura, R; Moriyama, K; Yasukawa, K et al. (1998) Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res 13:777-85
Xu, C; Ji, X; Harris, M A et al. (1998) A clonal chondrocytic cell line derived from BMP-2/T antigen-expressing transgenic mouse. In Vitro Cell Dev Biol Anim 34:359-63
Reddy, S V; Roodman, G D (1998) Control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8:1-17
Chen, D; Ji, X; Harris, M A et al. (1998) Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305
Roodman, G D (1998) Osteoclast differentiation and activity. Biochem Soc Trans 26:7-13
Hughes, D E; Boyce, B F (1997) Apoptosis in bone physiology and disease. Mol Pathol 50:132-7
Mundy, G R (1997) Growth factors as potential therapeutic agents in osteoporosis. Instr Course Lect 46:495-8

Showing the most recent 10 out of 49 publications